Journal of Cancer Research and Therapeutics Close
 

Table 1: Nuclear morphology analysis by 4,6-diamidino-2-phenylindole-staining in DU145 cells treated with 0.05 μM doxorubicin and 0.95 μg/ml zinc oxide nanofluids, alone or in combination, in the absence and presence of irradiation

Table 1: Nuclear morphology analysis by 4,6-diamidino-2-phenylindole-staining in DU145 cells treated with 0.05 μM doxorubicin and 0.95 μg/ml zinc oxide nanofluids, alone or in combination, in the absence and presence of irradiation